CamiloE.FadulMD

Clinical Trials

• Combination Chemotherapy for Patients With Brain Cancer Start of enrollment: 1996 Aug 01

  Completed

  Phase 2

• Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme Start of enrollment: 1997 Mar 01

  Completed

  Phase 1

• Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy Start of enrollment: 2002 Mar 01

  Completed

  Phase 2

• Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 May 01

  Completed

  Phase 2

• A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01

  Completed

  Phase 2

• Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) Start of enrollment: 2010 Mar 01

  Completed

  Early Phase 1

• Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01

  Completed

  Phase 1, Phase 2

• Derivation of Tumor Specific Hybridomas Start of enrollment: 2014 Jan 01

  Terminated

  Phase 1

• Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 May 01

  Terminated

  Phase 2

• Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas Start of enrollment: 2020 Feb 28

  Recruiting

• Phase I EGFR BATs in Newly Diagnosed Glioblastoma Start of enrollment: 2018 Mar 01

  Active, not recruiting

  Phase 1

• BATs in Patients With Breast Cancer and Leptomeningeal Metastases Start of enrollment: 2019 Feb 26

  Terminated

  Phase 1

• Join now to see all